2020336Drew Reference List

 

The Use of Tranexamic Acid in Tactical Combat Casualty Care:
TCCC Proposed Change 20-02

Fall 2020

Brendon Drew, DO; Jonathan Auten, DO; Andre Cap, MD, PhD; Travis Deaton, MD; Benjamin Donham, MD; Warren Dorlac, MD; Joseph DuBose, MD, FACS, FCCM; Andrew D. Fisher, MD, PA-C; Alan J. Ginn; James Hancock, MD; John B. Holcomb, MD; John Knight, MD; Ryan Knight, MD; Albert “Ken” Koerner, MD; Lanny Littlejohn, MD; Matthew J. Martin, MD; John Morey; Jonathan Morrison, MD; Martin Schreiber, MD; Philip C. Spinella, MD, FCCM; Benjamin Walrath, MPH, MD; Frank Butler, MD

References

  1. El-Menyar A, Sathian B, Asim M, et al. Efficacy of prehospital administration of tranexamic acid in trauma patients: a meta-analysis of the randomized controlled trials. Am J Emerg Med. 2018;36:1079-1087.
  2. Mannan S, Ali M, Mazur L, et al. The use of tranexamic acid in total elbow replacement to reduce post-operative wound infection. J Bone Jt Infect. 2018;3(2):104-107.
  3. Wang W, Yu J. Tranexamic acid reduces blood loss in intertrochanteric fractures: a meta-analysis from randomized controlled trials. Medicine (Baltimore). 2017;96(52):e9396.
  4. Vara AD, Koueiter DM, Pinkas DE, et al. Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial. J Shoulder Elbow Surg. 2017;26(8):1383-1389.
  5. Lack WD, Crist BD, Seymour RB, et al. Effect of tranexamic acid on transfusion: a randomized clinical trial in acetabular fracture surgery. J Orthop Trauma. 2017;31(10):526-530.
  6. Kayupov E, Fillingham YA, Okroj K, et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2017;99(5):373-378.
  7. Haghighi M, Mardani-Kivi M, Mirbolook A, et al. Does tranexamic acid reduce bleeding during femoral fracture operation? Arch Bone Jt Surg. 2017;5(2):103-108.
  8. Demos HA, Lin ZX, Barfield WR, et al. Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. J Arthroplasty. 2017;32(8):2375-2380.
  9. Cornell C. Tranexamic acid should be considered in fracture surgery. J Orthop Trauma. 2017;31(10):511-512.
  10. Rosenstein AD MY, Thompson S, Kaye AD. Benefits of limited use of a tourniquet combined with intravenous tranexamic acid during total knee arthroplasty. Oschner Journal. 2016;16(4):443-449.
  11. Pitta M, Zawadsky M, Verstraete R, et al. Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. Transfusion. 2016;56(2):466-471.
  12. Jennings JD, Solarz MK, Haydel C. Application of tranexamic acid in trauma and orthopedic surgery. Orthopedic Clinics of North America. 2016;47(1):137-143.
  13. Hogan CA, Golightly LK, Phong S, et al. Perioperative blood loss in total hip and knee arthroplasty: Outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med. 2016;4:2050312116637024.
  14. Abildgaard JT, McLemore R, Hattrup SJ. Tranexamic acid decreases blood loss in total shoulder arthroplasty and reverse total shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25(10):1643-1648.
  15. Bagsby DT, Samujh CA, Vissing JL, et al. Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral total knee arthroplasty. J Arthroplasty. 2015;30(12):2106-2109.
  16. Formby PM, Pickett AM, Van Blarcum GS, et al. The use of intravenous tranexamic acid in patients undergoing total hip or knee arthroplasty: a retrospective analysis at a single military institution. Mil Med. 2015;180(10):1087-1090.
  17. Wingerter SA, Keith AD, Schoenecker PL, et al. Does tranexamic acid reduce blood loss and transfusion requirements associated with the periacetabular osteotomy? Clin Orthop Relat Res. 2015;473(8):2639-2643.
  18. Kim C, Park SS, Davey JR. Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence. J Blood Med. 2015;6:239-244.
  19. Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387-389.
  20. Whiting DR, Gillette BP, Duncan C, et al. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res. 2014;472(1):66-72.
  21. Sabatini L, Atzori F, Revello S, et al. Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch Orthop Trauma Surg. 2014;134(11):1609-1614.
  22. Kim TK, Chang CB, Kang YG, et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1870-1878.
  23. Karam JA, Bloomfield MR, DiIorio TM, et al. Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J Arthroplasty. 2014;29(3):501-503.
  24. Aguilera X, Martinez-Zapata MJ, Bosch A, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am. 2013;95(22):2001-2007.
  25. Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012;94(13):1153-1159.
  26. Carabini LM, Moreland NC, Vealey RJ, et al. A randomized controlled trial of low-dose tranexamic acid versus placebo to reduce red blood cell transfusion during complex multilevel spine fusion surgery. World Neurosurg. 2018;110:e572-e579.
  27. Seddighi A NA, Seddighi AS, Zali A, et al. The role of tranexamic acid in prevention of hemorrhage in major spinal surgeries. Asian J Neurosurg. 2017;12(3):501-505.
  28. Raksakietisak M, Sathitkarnmanee B, Srisaen P, et al. Two doses of tranexamic acid reduce blood transfusion in complex spine surgery: a prospective randomized study. Spine (Phila Pa 1976). 2015;40(24):E1257-1263.
  29. Badeaux J, Hawley D. A systematic review of the effectiveness of intravenous tranexamic acid administration in managing perioperative blood loss in patients undergoing spine surgery. J Perianesth Nurs. 2014;29(6):459-465.
  30. Wang Q, Liu J, Fan R, et al. Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. Eur Spine J. 2013;22(9):2035-2038.
  31. Cansancao AL, Conde-Green A, David JA, et al. Use of tranexamic acid to reduce blood loss in liposuction. Plast Reconstr Surg. 2018;141(5):1132-1135.
  32. Rohrich RJ, Cho MJ. The role of tranexamic acid in plastic surgery: review and technical considerations. Plast Reconstr Surg. 2018;141(2):507-515.
  33. Takeyama M, Takeuchi F, Gosho M, et al. Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes. Clin Ophthalmol. 2018;12:35-41.
  34. Eftekharian HR, Rajabzadeh Z. The efficacy of preoperative oral tranexamic acid on intraoperative bleeding during rhinoplasty. J Craniofac Surg. 2016;27(1):97-100.
  35. Das A, Chattopadhyay S, Mandal D, et al. Does the preoperative administration of tranexamic acid reduce perioperative blood loss and transfusion requirements after head neck cancer surgery? A randomized, controlled trial. Anesthesia: Essays and Researches. 2015;9(3):384.
  36. Twym-Barimah E, Abdelgadir I, Gordon M, et al. Systemic review with meta-analysis: the efficacy of tranexamic acid in upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2020;51:1004-1013.
  37. Eftekharian H, Vahedi R, Karagah T, et al. Effect of tranexamic acid irrigation on perioperative blood loss during orthognathic surgery: a double-blind, randomized controlled clinical trial. J Oral Maxillofac Surg. 2015;73(1):129-133.
  38. Christabel A, Muthusekhar MR, Narayanan V, et al. Effectiveness of tranexamic acid on intraoperative blood loss in isolated Le Fort I osteotomies-a prospective, triple blinded randomized clinical trial. J Craniomaxillofac Surg. 2014;42(7):1221-1224.
  39. Sankar D, Krishnan R, Veerabahu M, et al. Evaluation of the efficacy of tranexamic acid on blood loss in orthognathic surgery. A prospective, randomized clinical study. Int J Oral Maxillofac Surg. 2012;41(6):713-717.
  40. Eckert MJ, Wertin TM, Tyner SD, et al. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma Acute Care Surg. 2014;77(6):852-858; discussion 858
  41. Nishijima DK, VanBuren J, Hewes HA, et al. Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial. Trials. 2018;19(1):593.
  42. Hamele M, Aden J, Borgman MA. Tranexamic acid in pediatric combat trauma requiring massive transfusions and mortality. Journal of Trauma and Acute Care Surgery: April 6, 2020. Epub ahead of print. doi:10.1097/TA.0000000000002701
  43. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105-2116.
  44. Rowell SE, Meier EN, McKnight B, et al. Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurological outcomes in patients with moderate or severe traumatic brain injury. JAMA. 2020. Accepted for publication.
  45. Schauer SG, Naylor JF, Wiese J, et al. Prehospital administration of tranexamic acid by ground forces in Afghanistan. Journal of Special Operations Medicine. 2017;17(3):55-58.
  46. Fisher A, Carius B, April M, et al. An analysis of ahderence to Tactical Combat Casualty Care Guidelines for the administration of tranexamic acid. Journal of Emergency Medicine. 2019;57(5):646-652.
  47. Horrow JC VRD, Strong MD, Grunewald KE, et al. The dose-response relationship of tranexamic acid. Anesthesiology. 1995;82(2):383-392.
  48. Waldow T, Szlapka M, Haferkorn M, et al. Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures. Clin Hemorheol Microcirc. 2013;55(4):457-468.
  49. Zufferey PJ, Lanoiselee J, Chapelle C, et al. Intravenous tranexamic acid bolus plus infusion is not more effective than a single bolus in primary hip arthroplasty: a randomized controlled trial. Anesthesiology. 2017;127(3):413-422.
  50. Kundu R, Das A, Basunia SR, et al. Does a single loading dose of tranexamic acid reduce perioperative blood loss and transfusion requirements after total knee replacement surgery? A randomized, controlled trial. J Nat Sci Biol Med. 2015;6(1):94-99.
  51. Ishii Y, Noguchi H, Sato J, et al. Effect of a single injection of tranexamicacid on blood loss after primary hybrid TKA. Knee. 2015;22(3):197-200.
  52. Xie B, Tian J, Zhou DP. Administration of tranexamic acid reduces postoperative blood loss in calcaneal fractures: a randomized controlled trial. J Foot Ankle Surg. 2015;54(6):1106-1110.
  53. Heyns M, Knight P, Steve AK, et al. A single preoperative dose of tranexamic acid reduces perioperative blood loss: a meta-analysis. Ann Surg. 2020 Mar 27. doi:10.1097/SLA.0000000000003793. Online ahead of print.
  54. Dickey NW, Jenkins D. Defense Health Board recommendation for the addition of tranexamic acid to the Tactical Combat Casualty Care guidelines. Defense Health Board Memorandum 2011:1-12. Available at https://www.jsomonline.org/TCCC/05%20TCCC%20 Change%20Documents/11-2%20DHB%20Memo%20110923%20TXA.pdf. Accessed January 19, 2017.
  55. Neeki MM, Dong F, Toy J, et al. Tranexamic acid in civilian trauma care in the California Prehospital Antifibrinolytic Therapy Study. West J Emerg Med. 2018;19(6):977-986.
  56. Goodloe JM HD, McAnallen D, Reed H. How can tranexamic acid help in EMS? EMS World. 2013;42(5):5-6.
  57. Kunze-Szikszay N, Krack LA, Wildenauer P, et al. The pre-hospital administration of tranexamic acid to patients with multiple injuries and its effects on rotational thrombelastometry: a prospective observational study in pre-hospital emergency medicine. Scand J Trauma Resusc Emerg Med. 2016;24(1):122.
  58. Mrochuk M, et al. Rural trauma patients cannot wait: tranexamic acid administration by helicopter emergency medical services. Air Med J. 2015;34(1):37-39.
  59. Stein P, Studt JD, Albrecht R, et al. The impact of prehospital tranexamic acid on blood coagulation in trauma patients. Anesth Analg. 2018;126(2):522-529.
  60. Boutonnet M, Abback P, Le Sache F, et al. Tranexamic acid in severe trauma patient managed in a mature trauma care system. J Trauma Acute Care Surg. 2018;84(6S suppl 1):S54-S62.
  61. Paudyal P, Smith J, Robinson M, et al. Tranexamic acid in major trauma: implementation and evaluation across South West England. Eur J Emerg Med. 2017;24(1):44-48.
  62. Zickenrott V, Greb I, Henkelmann A, et al. [Tranexamic acid in the German emergency medical service: a national survey]. Anaesthesist. 2017;66(4):249-255.
  63. Lipsky AM, Nadler R, Feinstein U, et al. Tranexamic acid in the prehospital setting: Israeli Defense Forces’ initial experience. Injury. 2014;45(1):66-70.
  64. Cornelius BG, McCarty K, Hylan K, et al. Tranexamic acid: promise or panacea: the impact of air medical administration of tranexamic acid on morbidity, mortality, and length of stay. Adv Emerg Nurs J. 2018;40(1):27-35.
  65. Butler FK, Giebner SD (editors). Prehospital Trauma Life Support Textbook, Ed 9 (Military). Burlington, MA, Jones and Bartlett Learning, 2019.
  66. Perel P, Kawahara T, Morris Z, et al. CRASH-2 (Clinical Randomisation of an Anti brinolytic in Signi cant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury – a nested, randomised, placebo-controlled trial. Health Technology Assessment. 2012;16(13).
  67. Harvey V PJ, Kim P. Does the use of tranexamic acid improve trauma mortality? Ann Emerg Med. 2014;63(4):460-462.
  68. Zehtabchi S, Abdel Baki SG, Falzon L, et al. Traexamic acid for traumatic brain injury: a systematic review and meta-analysis. American Journal of Emergency Medicine. 2014;32:1503-1509.
  69. Mahmood A, Roberts I, Shakur H, et al. Does tranexamic acid improve outcomes in traumatic brain injury? BMJ. 2016;354:i4814.
  70. Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748-e753.
  71. Chakroun-Walha O, Samet A, Jerbi M, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2018.
  72. Chan DY, Tsang AC, Li LF, et al. Improving survival with tranexamic acid in cerebral contusions or traumatic subarachnoid hemorrhage: univariate and multivariate analysis of independent factors associated with lower mortality. World Neurosurgery. 2019 epub ahead of print.
  73. Morte D, Lammers D, Bigham J, et al. Tranexamic acid (TXA) administration following head trauma in a combat setting: does TXA result in improved neurologic outcomes? J Trauma Acute Care Surg. 2019 Jul;87(1):125-129.
  74. Weng S, Wang W, Wei Q, et al. Effect of tranexamic acid in patients with traumatic brain injury: a systematic review and meta-analysis. World Neurosurg. 2018.
  75. Cap A. CRASH-3: a win for patients with traumatic brain injury. Lancet. 2019. https://doi.org/10.1016/S0140-6736(19)32312-8
  76. Grassin-Delyle S, Theusinger OM, Albrecht R, et al. Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis. Anaesthesia. 2018;73(6):719-729.
  77. Taam J, Yang QJ, Pang KS, et al. Current evidence and future directions of tranexamic acid use, efficacy, and dosing for major surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia. 2020;34(3):782-790.
  78. Picetti R, Shakur-Still H, Medcalf RL, et al. What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. Blood Coagul Fibrinolysis. 2019;30(1):1-10.
  79. Vu EN WW, Yeung TC, Callaway DC. Intramuscular tranexamic acid in tactical and combat settings. Journal of Special Operations Medicine. 2018;18(1):62-68.
  80. Spinella PC, Thomas KA, Turnbull IR, et al. The immunologic effect of early intravenous two and four gram bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding (TAMPITI): a randomized, double-blind, placebo-controlled, single-center trial. Frontiers in Immunology. 2020. Accepted for publication.
  81. Brown JB, Neal MD, Guyette FX, et al. Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) trial: addressing the knowledge gaps. Prehosp Emerg Care. 2015;19(1):79-86.
  82. Guyette FX, Brown JB, Zenati MS, et al. Tranexamic acid during prehospital transport in patients at risk of hemorrhage following injury: a randomized, double-blind, placebo controlled, clinical trial. JAMA Surg. 2020. Accepted for publication.
  83. Apipan B, Rummasak D, Narainthonsaenee T. The effect of different dosage regimens of tranexamic acid on blood loss in bimaxillary osteotomy: a randomized, double-blind, placebo-controlled study. Int J Oral Maxillofac Surg. 2018;47(5):608-612.
  84. Wang C, Kang P, Ma J, et al. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb Res. 2016;141:119-123.
  85. Volquind D, Zardo RA, Winkler BC, et al. Use of tranexamic acid in primary total knee replacement: effects on perioperative blood loss. Braz J Anesthesiol. 2016;66(3):254-258.
  86. Baker JE, Pavenski K, Pirani RA, et al. Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation. Can J Anaesth. 2015;62(11):1179-1187.
  87. Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial. Hip Int. 2014;24(1):63-68.
  88. Stansfield R, Morris D, Jesulola E. The use of tranexamic acid (TXA) for the management of haemorrhage in trauma patients in the preshospital environment: literature review and descriptive analysis of principal themes. Shock. 2020;53(3):277-283.
  89. Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376(2):136-148.
  90. Lin Z, Xiaoyi Z. Tranexamic acid-associated seizures: a meta-analysis. Seizure. 2016;36:70-73.
  91. Lecker I, Wang DS, Whissell PD, et al. Tranexamic acid-associated seizures: causes and treatment. Ann Neurol. 2016;79(1):18-26.
  92. Sharma V, Katznelson R, Jerath A, et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11,529 patients. Anaesthesia. 2014;69(2):124-130.
  93. Koster A, Borgermann J, Zittermann A, et al. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth. 2013;110(1):34-40.
  94. Lecker I, Wang DS, Romaschin AD, et al. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. Journal of Clinical Investigation. 2012;122(12):4654-4666.
  95. Keyl C, et al. High-dose tranexamic acid is related to increased of generalized seizures after aortic valve replacement. Europen Journal of Cardiothoracic Surgery. 2011;39:e114-e121.
  96. Martin K, Knorr J, Breuer T, et al. Seizures after open heart surgery: comparison of e-aminocaproic acid and tranexamic acid. Journal of Cardiothoracic and Vascular Anesthesia. 2011;25(1):20-25.
  97. Murkin JM, Falter F, Young B, et al. High dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010;110:350-353.
  98. CRASH-3 Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial. Lancet. 2019 Nov 9;394(10210):1713-1723.
  99. Butler FK, Greydanus DJ. Committee on Tactical Combat Casualty Care meeting minutes: 10-11 September 2019. Journal of Special Operations Medicine. 2020;20(1):148-161.
  100. Acker SA, Ross JT, Partrick DA, et al. Glasgow motor scale alone is equivalent to Glascow Coma Scale in identifying children at risk for serious traumatic brain injury. J Trauma Acute Care Surg. 2014;77(2):304-309.
  101. Coats TJ, Lecky FE. The CRASH-3 study: prehospital TXA for every injured patient? Emergency Medicine Journal. 2020;37:392-394.
  102. Valle EJ, Allen CJ, Van Haren RM, et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76(6):1373-1378.
  103. Boudreau RM, Deshpande KK, Day GM, et al. Prehospital tranexamic acid administration during aeromedical transport after injury. J Surg Res. 2019;233:132-138.
  104. CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377:1096-1101.
  105. Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2017;391(10116):125-132.
  106. Nishijima DK, Kuppermann N, Roberts I, et al. The effect of tranexamic acid on functional outcomes: an exploratory analysis of the CRASH-2 randomized controlled trial. Ann Emerg Med. 2019.
  107. Ageron F, Gayet-Ageron A, Ker K, et al. The effect of tranexamic acid by baseline risk in acute bleding patients: a meta-analysis of individual patient-level data from 28,333 patients. Br J Anesthesia. 2020;124:659-662.
  108. Diebel ME, Martin JV, Liberati DM, et al. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation. J Trauma Acute Care Surg. 2018;84(1):75-80.
  109. Naumann DN, Hazeldine J, Davies DJ, et al. Endotheliopathy of trauma is an on-scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study. Shock. 2018;49(4):420-428.
  110. Diebel LN, Martin JV, Liberati DM. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model. J Trauma Acute Care Surg. 2017;82(6):1080-1086.
  111. Jimenez JJ IJ, Lorente L, Rodriguez JM, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Critical Care. 2007;11(6).
  112. Levy JH. Antifibrinolytic therapy: new data and new concepts. Lancet. Published Online June 15, 2010. doi:10.1016/S0140-6736(10)60939-7.
  113. Jimenez JJ, Iribarren JL, Brouard M, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011;6:138.
  114. Diebel ME, Diebel LN, Manke CW, et al. Early tranexamic acid administration: A protective effect on gut barrier function following ischemia/reperfusion injury. J Trauma Acute Care Surg. 2015;79(6):1015-1022.
  115. Walker PF, Foster AD, Rothberg PA, et al. Tranexamic acid decreases rodent hemorrhagic shock-induced inflammation with mixed end-organ effects. PLoS One. 2018;13(11):e0208249.
  116. Teng Y, Liu Y, Jin H, et al. Anti-inflammatory effect of tranexamic acid against trauma-hemorrhagic shock-induced acute lung injury in rats. Exp Anim Jpn Assoc Lab Anim Sci. 2018;67(3):313-320.
  117. Grant AL, Letson HL, Morris JL, et al. Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study. J Orthop Surg Res. 2018;13(1):149.
  118. Peng Z, Ban K, LeBlanc A, et al. Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock. J Trauma Acute Care Surg. 2016;81(2):358-365.
  119. Wu X, Dubick M, Schwacha M, et al. Tranexamic acid attenuates the loss of lung barrier function in a rat model of polytrauma and hemorrhage with resuscitation. Shock. 2017;47(4):500-505.
  120. Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Critical Care. 2019;23(98):1-74.
  121. Huebner BR, Dorlac WC, Cribari C. Tranexamic acid use in prehospital uncontrolled hemorrhage. Wilderness Environ Med. 2017;28(2S):S50-S60.
  122. Wright C. Battlefield administration of tranexamic acid by combat troops: a feasibility analysis. J R Army Medical Corps. 2014160:271-272.
  123. Culligan WB. Tranexamic acid autoinjector for prehospital care of noncompressible hemorrhage. J Trauma. 2011;71(5):S501-S502.
  124. Sano M HH, Kojima C, Akimoto T. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers. Japanese Journal of Clinical Pharmacology and Therapeutics. 1976;7:375-382.
  125. Pilbrant Å, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20:65-72.
  126. Puigdellivol E CM, Moreno J, et al. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man. Int J Clin Pharmacol Ther Toxicol. 1985;23(6):298-301.
  127. Grassin-Delyle S, et al. Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta-analysis of pharmacokinetic studies in healthy volunteers. Fundamental & Clinical Pharmacology. 2019. 10.1111/fcp.12474.
  128. Spruce M, Beyer C, Caples C, et al. Pharmacokinetics of tranexamic acid given as an intramuscular injection compared to intravenous infusion in a swine model of ongoing hemorrhage. Shock. 2020;53(6):754-760.
  129. DeSoucy E, Davidson A, Hoareau G, et al. The pharmacokinetics of tranexamic acid via intravenous, intraosseous, and intramuscular routes in a porcine (sus scrofa) hemorrhagic shock model. Journal of Special Operations Medicine. 2019;19(4):80-84.
  130. Lewis P, Wright C. Saving the critically injured trauma patient: a retrospective analysis of 1000 uses of intraosseous access. Emerg Med J. 2015;32(6):463-467.
  131. Ranger Medic Handbook.
  132. Androski C, Bianchi W, Robinson DL, et al. Case series on 2g TXA flush from the 75th Ranger Regiment Casualty Database. J Spec Oper Med. 2020.
  133. Lallemand MS, Moe DM, McClellan JM, et al. No intravenous access, no problem: Intraosseous administration of tranexamic acid is as effective as intravenous in a porcine hemorrhage model. J Trauma Acute Care Surg. 2018;84(2):379-385.
  134. Boysen SR, Pang JM, Mikler JR, et al. Comparison of tranexamic acid plasma concentrations when administered via intraosseous and intravenous routes. Am J Emerg Med. 2017;35(2):227-233.
  135. CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage. (CRASH-2); a randomized, placebo-controlled trial. Lancet. 2010;376:23-32.
  136. Morrison JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113-119.
  137. Hedlund PO. Antifibrinolytic therpay with cyklokapron in connection with prostatectomy. Scand J Urol Nephrol. 1969;3:177-182.
  138. Derickson MJ, McClellan JM, Marko ST, et al. The effects of hemorrhage on the pharmacokinetics of tranexamic acid in a swine model. J Trauma Acute Care Surg. 2018;85(1S suppl 2):S44-S48.
  139. World Health Organization. Updated WHO recommendation on tranexamic acid for the treatment of postpartum hemorrhage. https:// apps.who.int/iris/bitstream/handle/10665/259379/WHO-RHR-17.21-eng.pdf;jsessionid=D235A0BAD2BB510EAF0445D669B92058?sequence=1 Accessed 18 Aug 2019.
  140. Studer N, Yassin A, Keen D. Compatibility of hydroxyethyl starch and tranexamic acid for battlefield co-administration. Mil Med. 2016;181:1305-1307.
  141. Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis. J Arthroplasty. 2018;33(10):3070-3082 e3071.
  142. Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res. 2011;469(10):2874-2880.
  143. Huang F, Wu D, Ma G, et al. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186(1):318-327.
  144. Yu X, Li W, Xu P, et al. Safety and efficacy of tranexamic acid in total knee arthroplasty. Medical Science Monitor. 2015;21:3095-3103.
  145. Valerio IL, Campbell P, Sabino J, et al. TXA in combat casualty care-does it adversely affect extremity reconstruction and flap thrombosis rates? Mil Med. 2015;180(3 suppl):24-28.
  146. Huang Z, Xie X, Li L, et al. Intravenous and topical tranexamic acid alone are superior to tourniquet use for primary total knee arthroplasty: a prospective, randomized controlled trial. J Bone Joint Surg Am. 2017;99(24):2053-2061.
  147. Li JF, Li H, Zhao H, et al. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. J Orthop Surg Res. 2017;12(1):22.
  148. Evangelista PJ, Aversano MW, Koli E, et al. Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. Orthop Clin North Am. 2017;48(2):109-115.
  149. Farrow LS, Smith TO, Ashcroft GP, et al. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82(6):1458-1470.
  150. Gausden EB, Qudsi R, Boone MD, et al. Tranexamic acid in orthopaedic trauma surgery: a meta-analysis. J Orthop Trauma. 2017;31(10):513-519.
  151. Amer KM, Rehman S, Amer K, et al. Efficacy and safety of tranexamic acid in orthopaedic fracture surgery: a meta-analysis and systematic literature review. J Orthop Trauma. 2017;31(10):520-525.
  152. Khan M, Jehan F, Bulger EM, et al. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial. J Trauma Acute Care Surg. 2018;85(5):851-857.
  153. Glover TE, Sumpter JE, Ercole A, et al. Pulmonary embolism following complex trauma: UK MTC observational study. Emerg Med J. 2019;36:608-612.
  154. Myers SP, Kutcher ME, Rosengart MR, et al. Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg. 2019;86(1):20-27.
  155. Chornenki NLJ, Um KJ, Mendoza PA, et al. Risk of venous and arterial thrombosis in non-surgical patients receivings systemic tranexamic acid: a systematic review and meta-analysis. Thrombosis Research. 2019;179:81-86.
  156. Ekeh AP, Dominguez KM, Markert RJ, et al. Incidence and risk factors for deep venous thrombosis after moderate and severe brain injury. J Trauma. 2010;68(4):912-915.
  157. Reiff DA, Haricharan RN, Bullington NM, et al. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436-1440.
  158. Adams RC, Hamrick M, Berenguer C, et al. Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population. J Trauma. 2008;65(2):300-306; discussion 306-308.
  159. Howard JT, Stockinger ZT, Cap AP, et al. Military use of tranexamic acid in combat trauma: does it matter? J Trauma Acute Care Surg. 2017;83(4):579-588.
  160. Johnston LR, Elster EA, Bradley MJ. JAMA Surgery. 2018;153(2):169-175.
  161. Yates J, Perelman I, Khair S, et al. Exclusion criteria and adverse events in preoperative trials of tranexamic acid: a systematic review and meta-analysis. Transfusion. 2019;59(2):806-824.
  162. Lier H, Maegele M, Shander A. Tranexamic acid for acute hemorrhag: a narrative review of landmark studies and a critical reappraisal of its use over the last decade. Anesth Analg. 2019 Dec;129(6):1574-1584.
  163. De Guzman R, Polykratis A, Sonden J, et al. Stability of tranexamic acid after 12-week storage at temperatures from -20°C to 50°C. Pre-hosp Emerg Care. 2013;17:394-400.
  164. Donnelly RF. Stability of tranexamic acid mouth rinse. Int J Pharmaceut Compound. 2018;22(5):412-416.
  165. Tricoci P, Allen JM, Kramer JM. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301:831-841.